Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

Both of Iowa’s U.S. senators met yesterday with “top officials” at the U.S. Health and Human Services Department (HHS) to share Iowa hospitals’ concerns about drug manufacturers unilaterally ending or imposing conditions on 340B pricing for their products.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga